Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level-Reference-Cited by-同舟云学术

Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level

Published:2016-08-12 Issue:2 Volume:159 Page:357-365
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Verschoor A. M. F.,Kuijer A.,Verloop J.,Van Gils C. H.,Sonke G. S.,Jager A.,van Dalen T.,Elias S. G.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-016-3940-7.pdf

Reference22 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. doi: 10.3322/caac.21262

2. Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J (2002) Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975–1999. J Natl Cancer Inst 94(21):1626–1634

3. National Institutes of Health Consensus Development Panel (1986) National institutes of health consensus development conference statement: adjuvant chemotherapy for breast cancer. CA Cancer J Clin 36:42–47

4. National Institutes of Health Consensus Development Panel (1991) NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265:391–395

5. National Institutes of Health Consensus Development Panel (2001) National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 30: 5–15. Netherlands Comprehensive Cancer Organisation (IKNL). Cijfers over kanker. http://www.cijfersoverkanker.nl/

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to changing guidelines among real-world early breast cancer patient in Finland over two decades;2023-06-26

2. Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study;Radiology;2023-05-01

3. Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA;Breast Cancer Research and Treatment;2022-03-03

4. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I–III Breast Cancer;Journal of the National Comprehensive Cancer Network;2019-06

5. Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer;Frontiers in Oncology;2018-08-10